S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

AKBA Akebia Therapeutics Inc

1.8798

0.0898 (5.02%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Akebia Therapeutics Charts.

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Akebia Therapeutics Charts.

Akebia Therapeutics Inc News

Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Wednesday 18 December 2024 (4 days ago) • PR Newswire (US)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 3 December 2024 (3 weeks ago) • PR Newswire (US)

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis
Tuesday 3 December 2024 (3 weeks ago) • PR Newswire (US)

Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
Monday 25 November 2024 (4 weeks ago) • PR Newswire (US)

Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease
Thursday 14 November 2024 (1 month ago) • PR Newswire (US)

Akebia Therapeutics to Present at the Jefferies London Healthcare Conference
Tuesday 12 November 2024 (1 month ago) • PR Newswire (US)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Thursday 7 November 2024 (1 month ago) • PR Newswire (US)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 1 November 2024 (2 months ago) • PR Newswire (US)

Akebia Therapeutics to Report Third Quarter 2024 Financial Results and Discuss Recent Business Highlights
Friday 1 November 2024 (2 months ago) • PR Newswire (US)

More Akebia Therapeutics Inc News Articles

DJ US General Retailers

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions